Clinical trials
Phase 2 Cancer Pain trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 3 |
| M.D. Anderson Cancer Center | 2 |
| Mansoura University | 2 |
| 3D Medicines | 1 |
| Barretos Cancer Hospital | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Dogwood Therapeutics Inc. | 1 |
| Fujian Cancer Hospital | 1 |
| InSightec | 1 |
| Instituto Nacional de Cancer, Brazil | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Pain | 24 |
| Pain | 9 |
| Neoplasms | 6 |
| Breast Neoplasms | 3 |
| Agnosia | 2 |
| Intractable Pain | 2 |
| Acute Pain | 1 |
| Arthralgia | 1 |
| Bone Neoplasms | 1 |
| Chronic Pain | 1 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.